Pricing
  1. JP-listed companies
  2. TRANS GENIC GROUP INC.
  3. Segments

TRANS GENIC GROUP INC.【JP:2342】Segments

Market cap
¥4.8B
P/E ratio
117.1x
Transgenics Group supports drug development through specialized lab services like genetically modified mice production and pharmaceutical testing, while also providing business consulting and importing various products from electrical equipment to tableware.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce

セグメント売上高

（単位：百万円）2015/032016/032017/032018/032019/032020/032021/032022/03
ＴＧＢＳ事業---1,5055,6418,2597,4867,823
Ｅコマース事業---1,3055,1955,3345,2844,700
その他---2004462,9252,2033,123
ＣＲＯ事業7991,0991,1511,2962,2371,942--
診断解析事業---808817867--

セグメント損益

（単位：百万円）2015/032016/032017/032018/032019/032020/032021/032022/03
ＴＧＢＳ事業---4587370325271
Ｅコマース事業---63982234157
その他---394928891115
ＣＲＯ事業84129244128315-36--
診断解析事業---554326--